# RANOLAZINE
> **ANDA212788** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2022-05-05
## Drug
- **FDA Application Number:** ANDA212788
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RANOLAZINE
- **Generic name:** RANOLAZINE
- **Active ingredients:** RANOLAZINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD III
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2022-05-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212788)
---
*MORVS · CC0 1.0*